Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04230759
Title Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma. A Multicenter, Randomized, Phase II Trial of the German Anal Cancer Study Group (RADIANCE)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Goethe University
Age Groups: senior | adult
Covered Countries DEU | AUT

No variant requirements are available.